Nearly half of the HCC patients in the database carried TRiC subunit gene alterations, with highest mutation rates in CCT3 (27%), CCT5 (18%), and TCP1 (12%) (Figure 5). This evidence concerns the gene MARVELD2 and hepatocellular carcinoma.